Author:
Midttun Øivind,Ulvik Arve,Meyer Klaus,Zahed Hana,Giles Graham G.,Manjer Jonas,Sandsveden Malte,Langhammer Arnulf,Sørgjerd Elin Pettersen,Behndig Annelie F.,Johansson Mikael,Freedman Neal D.,Huang Wen-Yi,Chen Chu,Prentice Ross,Stevens Victoria L.,Wang Ying,Le Marchand Loïc,Weinstein Stephanie J.,Cai Qiuyin,Arslan Alan A.,Chen Yu,Shu Xiao-Ou,Zheng Wei,Yuan Jian-Min,Koh Woon-Puay,Visvanathan Kala,Sesso Howard D.,Zhang Xuehong,Gaziano J. Michael,Fanidi Anouar,Robbins Hilary A.,Brennan Paul,Johansson Mattias,Ueland Per M.
Abstract
AbstractCirculating concentrations of metabolites (collectively called kynurenines) in the kynurenine pathway of tryptophan metabolism increase during inflammation, particularly in response to interferon-gamma (IFN-γ). Neopterin and the kynurenine/tryptophan ratio (KTR) are IFN-γ induced inflammatory markers, and together with C-reactive protein (CRP) and kynurenines they are associated with various diseases, but comprehensive data on the strength of associations of inflammatory markers with circulating concentrations of kynurenines are lacking. We measured circulating concentrations of neopterin, CRP, tryptophan and seven kynurenines in 5314 controls from 20 cohorts in the Lung Cancer Cohort Consortium (LC3). The associations of neopterin, KTR and CRP with kynurenines were investigated using regression models. In mixed models, one standard deviation (SD) higher KTR was associated with a 0.46 SD higher quinolinic acid (QA), and 0.31 SD higher 3-hydroxykynurenine (HK). One SD higher neopterin was associated with 0.48, 0.44, 0.36 and 0.28 SD higher KTR, QA, kynurenine and HK, respectively. KTR and neopterin respectively explained 24.1% and 16.7% of the variation in QA, and 11.4% and 7.5% of HK. CRP was only weakly associated with kynurenines in regression models. In summary, QA was the metabolite that was most strongly associated with the inflammatory markers. In general, the inflammatory markers were most strongly related to metabolites located along the tryptophan–NAD axis, which may support suggestions of increased production of NAD from tryptophan during inflammation.
Funder
Australian National Health and Medical Research Council
National Institutes of Health
National Cancer Institute
National Institute of Environmental Health Sciences
Centers for Disease Control and Prevention
State of Maryland
Maryland Cigarette Restitution Fund
National Health and Medical Research Council
Publisher
Springer Science and Business Media LLC